Larger clinical trials are underway to evaluate the efficacy of STAR in broader patient populations, the team added.
Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy manufacturing, positioning India as a rising hub for global biotherapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback